tetraiodothyroacetic acid has been researched along with Angiogenesis, Pathologic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Mousa, SA; Rajabi, M; Yalcin, M | 1 |
| Müller, AM; Nelson, PJ; Schmohl, KA; Spitzweg, C | 1 |
| Ahn, J; Choe, YS; Choi, JY; Kim, BT; Kim, H; Kim, JY; Koo, HJ; Lee, KH | 1 |
| Bharali, DJ; Darwish, NHE; Davis, PJ; Mousa, SA; Sell, S; Sudha, T | 1 |
| Nelson, PJ; Schmohl, KA; Spitzweg, C | 1 |
| Bharali, DJ; Davis, PJ; Mousa, SA; Yalcin, M | 1 |
| Bharali, DJ; Davis, FB; Davis, PJ; Lin, HY; Meng, R; Mousa, SA; Stain, SC; Sudha, T; Tang, HY; Yalcin, M | 1 |
| Choe, YS; Kang, CM; Koo, HJ; Lee, KC; Lee, S; Oh, YK | 1 |
| Carlsen, J; Göke, B; Heuer, H; Müller, AM; Nelson, PJ; Rühland, S; Salb, N; Schmohl, KA; Schwenk, N; Spitzweg, C; Wechselberger, A | 1 |
| Bharali, DJ; Davis, FB; Davis, PJ; Dyskin, E; Hercbergs, A; Lansing, L; Mousa, SA; Mousa, SS; Yalcin, M | 1 |
| Bharali, DJ; Bridoux, A; Davis, FB; Davis, PJ; Dyskin, E; Glinskii, A; Glinsky, GV; Hercbergs, AH; Lansing, L; Lin, HY; Ma, J; Mousa, SA; Mousa, SS; Yalcin, M | 1 |
2 review(s) available for tetraiodothyroacetic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Thyroid Hormone Effects on Mesenchymal Stem Cell Biology in the Tumour Microenvironment.
Topics: Animals; Humans; Integrin alphaVbeta3; Mesenchymal Stem Cells; Neoplasms; Neovascularization, Pathologic; Thyroid Hormones; Thyroxine | 2020 |
Tetrac as an anti-angiogenic agent in cancer.
Topics: Angiogenesis Inhibitors; Animals; Humans; Mesenchymal Stem Cells; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Thyroxine | 2019 |
9 other study(ies) available for tetraiodothyroacetic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred C57BL; Molecular Structure; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Structure-Activity Relationship; Thyroxine | 2018 |
Synthesis and characterization of
Topics: Animals; Brain Neoplasms; Carbocyanines; Cells, Cultured; Copper Radioisotopes; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Neovascularization, Pathologic; Positron-Emission Tomography; Thyroxine | 2020 |
Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Hypothyroidism; Integrin alphaVbeta3; Mice; Nanoparticles; Neovascularization, Pathologic; Receptors, Cell Surface; Thyroxine; Xenograft Model Antitumor Assays | 2017 |
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine | 2013 |
Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.
Topics: Animals; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Pancreatic Neoplasms; Thyroxine; Transplantation, Heterologous | 2013 |
64Cu-Labeled tetraiodothyroacetic acid-conjugated liposomes for PET imaging of tumor angiogenesis.
Topics: Animals; Cattle; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Drug Stability; Glioblastoma; Humans; Liposomes; Male; Mice; Neovascularization, Pathologic; Positron-Emission Tomography; Thyroxine | 2013 |
Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Cell Movement; Culture Media, Conditioned; Heterografts; Humans; Hyperthyroidism; Hypothyroidism; Integrin alphaVbeta3; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mesenchymal Stem Cells; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Specific Pathogen-Free Organisms; Spheroids, Cellular; Stromal Cells; Thyroxine; Triiodothyronine; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |
Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Topics: Animals; Carcinoma, Renal Cell; Cell Growth Processes; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Humans; Kidney Neoplasms; Lactic Acid; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Xenograft Model Antitumor Assays | 2009 |
Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Medullary; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Excipients; Female; Hemoglobins; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Thyroid Neoplasms; Thyroxine; Xenograft Model Antitumor Assays | 2010 |